In the UK, more than 2.5 million endoscopic procedures are carried out each year. Most are
performed under conscious sedation with benzodiazepines and opioids administered by the …

BACKGROUND & AIMS: Patients with Barrett's esophagus (BE) and high-grade dysplasia
(HGD) or early neoplasia increasingly receive endoscopic mucosal resection and …

This ESGE Position Statement defines the expected value of artificial intelligence (AI) for the
diagnosis and management of gastrointestinal neoplasia within the framework of the …

The prevalence of obesity, type 2 diabetes mellitus, and metabolic syndromes is increasing
globally. Minimally invasive metabobariatric (MB) endoscopic therapies are adjunct …

Background and Aims We aimed to develop duodenal mucosal resurfacing (DMR), a
minimally invasive upper endoscopic hydrothermal ablation procedure, to treat insulin …

AIM: To report outcomes on patients undergoing radiofrequency ablation (RFA) for early
oesophageal squamous neoplasia from a National Registry. METHODS: A Prospective …

Aims Duodenal mucosal resurfacing (DMR) is an endoscopic procedure developed to
improve metabolic parameters and restore insulin sensitivity in patients with diabetes. Here …

Background and Aims The Seattle protocol for endoscopic Barrett's esophagus (BE)
surveillance samples a small portion of the mucosal surface area, risking a potentially high …

Background and study aims Enhanced endoscopic imaging with chromoendoscopy may
improve dysplasia recognition in patients undergoing assessment of Barrett's esophagus …

Background and study aim: Mucosal neoplasia arising in Barrett's esophagus can be
successfully treated with endoscopic mucosal resection (EMR) followed by radiofrequency …